Briacell Therapeutics
Quarterly Financials
| Values in thousands | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $22 | $0 |
Gross Profit | 22 | -5 | ||
EBITDA | -7,142 | -5,126 | -5,695 | -12,701 |
EBIT | -7,169 | -5,152 | -5,767 | -12,705 |
Net Income | -6,291 | -5,802 | -1,214 | 1,715 |
Net Change In Cash | 0 | 0 | 22 | 0 |
Free Cash Flow | -5,920 | -6,955 | -4,035 | -5,083 |
Cash | 5,013 | 5,792 | 862 | 935 |
Basic Shares | 2,699 | 18,027 | 18,027 | 15,981 |
Annual Financials
| Values in thousands | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -82 | -20 | -19 | -19 |
EBITDA | -4,771 | -27,221 | -34,046 | -17,487 |
EBIT | -4,854 | -27,236 | -34,066 | -17,506 |
Net Income | -4,716 | -20,302 | -11,580 | -2,894 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -16,227 | |||
Free Cash Flow | -24,582 | -23,744 | -12,484 | -7,747 |
Cash | 862 | 21,251 | 41,041 | 57,268 |
Basic Shares | 16,454 | 15,619 | 15,518 | 15,269 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-01-31 | -$2.33 |
2024-10-31 | -$0.22 |
2024-07-31 | -$0.07 |
2024-04-30 | $0.11 |
